
    
      This is a single site, randomized, single-blind, controlled pilot study of Jing-
      Fu-Yau-Yu-Bau as a complementary therapy to treat mild to moderate plaque- type psoriasis
      during an 8-week period. We estimate to enroll 30 subjects (treatment group(N=15); controlled
      group(N=15)).
    
  